Exhibit 10.1
AGREEMENT OF MERGER AND
PLAN
OF REORGANIZATION
among
ACROSS AMERICA FINANCIAL SERVICES, INC.
ACROSS AMERICA ACQUISITION CORP. and
APRO
BIO PHARMACEUTICAL CORPORATION
NOVEMBER 17, 2008
|
|
|
Page
|
|
|
|
|
|
1.
|
The
Merger
|
1
|
|
1.1
|
Merger
|
1
|
|
1.2
|
Effective
Time
|
2
|
|
1.3
|
Articles of
Incorporation, By-laws, Directors and Officers.
|
2
|
|
1.4
|
Assets and
Liabilities
|
2
|
|
1.5
|
Manner and
Basis of Converting Shares.
|
3
|
|
1.6
|
Surrender and
Exchange of Certificates
|
3
|
|
1.7
|
Warrants.
|
4
|
|
1.8
|
Parent Common
Stock
|
4
|
|
2.
|
Representations
and Warranties of the Company
|
4
|
|
2.1
|
Organization,
Standing, Subsidiaries, Etc.
|
5
|
|
2.2
|
Qualification
|
5
|
|
2.3
|
Capitalization
of the Company
|
5
|
|
2.4
|
Company
Stockholders
|
5
|
|
2.5
|
Corporate Acts
and Proceedings
|
5
|
|
2.6
|
Compliance with
Laws and Instruments
|
6
|
|
2.7
|
Binding
Obligations
|
6
|
|
2.8
|
Broker’s
and Finder’s Fees
|
6
|
|
2.9
|
Financial
Statements
|
6
|
|
2.10
|
Absence of
Undisclosed Liabilities
|
6
|
|
2.11
|
Changes/Indebtedness
|
7
|
|
2.12
|
Employee
Benefit Plans; ERISA
|
7
|
|
2.13
|
Title to
Property and Encumbrances
|
7
|
|
2.14
|
Litigation
|
8
|
|
2.15
|
Patents,
Trademarks, Etc.
|
8
|
|
2.16
|
Disclosure.
|
8
|
|
3.
|
Representations
and Warranties of Parent and Acquisition Corp.
|
8
|
|
3.1
|
Organization
and Standing
|
8
|
|
3.2
|
Corporate
Authority
|
9
|
|
3.3
|
Broker’s
and Finder’s Fees
|
9
|
|
3.4
|
Capitalization
of Parent
|
9
|
|
3.5
|
Acquisition
Corp.
|
9
|
|
3.6
|
Validity of
Shares
|
9
|
|
3.7
|
SEC Reporting
and Compliance
|
10
|
|
3.8
|
Financial
Statements
|
10
|
|
3.9
|
Governmental
Consents
|
11
|
|
3.10
|
Compliance with
Laws and Instruments
|
11
|
|
3.11
|
No General
Solicitation
|
11
|
|
3.12
|
Binding
Obligations
|
11
|
|
3.13
|
Absence of
Undisclosed Liabilities
|
11
|
|
3.14
|
Changes
|
11
|
|
3.15
|
Tax Returns and
Audits
|
12
|
|
3.16
|
Employee
Benefit Plans; ERISA
|
13
|
|
3.17
|
Litigation
|
13
|
|
4.
|
Additional
Representations, Warranties and Covenants of the
Stockholders
|
13
|
|
5.
|
Conduct of
Businesses Pending the Merger.
|
13
|
|
5.1
|
Conduct of
Business by the Company Pending the Merger
|
13
|
|
5.2
|
Conduct of
Business by Parent and Acquisition Corp. Pending the
Merger
|
14
|
|
6.
|
Additional
Agreements.
|
15
|
|
6.1
|
Access and
Information
|
15
|
|
6.2
|
Additional
Agreements
|
16
|
|
6.3
|
Publicity
|
16
|
|
6.4
|
Appointment of
Directors
|
16
|
|
6.5
|
Parent Name
Change and Exchange Listing
|
17
|
|
6.6
|
Reserved
|
17
|
|
6.7
|
Reserved
|
17
|
|
6.8
|
Private
Offering
|
17
|
|
7.
|
Conditions of
Parties’ Obligations.
|
17
|
|
7.1
|
Company
Obligations
|
17
|
|
7.2
|
Parent and
Acquisition Corp. Obligations
|
18
|
|
8.
|
Non-Survival of
Representations and Warranties
|
20
|
|
9.
|
Amendment of
Agreement
|
20
|
|
10.
|
Definitions
|
21
|
|
11.
|
Closing
|
25
|
|
12.
|
Termination
Prior to Closing.
|
25
|
|
12.1
|
Termination of
Agreement
|
25
|
|
12.2
|
Termination of
Obligations
|
26
|
|
13.
|
Miscellaneous.
|
26
|
|
13.1
|
Notices
|
26
|
|
13.2
|
Entire
Agreement
|
27
|
|
13.3
|
Expenses
|
27
|
|
13.4
|
Time
|
27
|
|
13.5
|
Severability
|
27
|
|
13.6
|
Successors and
Assigns
|
27
|
|
13.7
|
No Third
Parties Benefited
|
27
|
|
13.8
|
Counterparts
|
28
|
|
13.9
|
Governing
Law
|
28
|
|
|
|
|
|
|
|
|
|
|
LIST OF
EXHIBITS AND SCHEDULES
|
|
|
|
Exhibits
|
|
|
A
|
Statement of
Merger
|
|
|
B
|
Articles of
Incorporation of the Company
|
|
|
C
|
By-laws of the
Company
|
|
|
D
|
Directors and
Officers of the Surviving Corporation
|
|
|
E
|
Subscription
and Lock Up agreement
|
|
|
F
|
Indemnification
Agreement of Parent Director
|
|
|
|
|
|
|
|
Company
Disclosure Schedules
|
|
|
1.5
|
Holders of
Parent Common Stock Post-Merger
|
|
|
1.7
(a)(i)
|
Treatment of
Company Warrants
|
|
|
2.4
|
Company
Stockholders
|
|
|
2.9
|
Financial
Statements
|
|
|
2.10
|
Undisclosed
Liabilities
|
|
|
2.11
|
Changes/Indebtedness
|
|
|
2.12
|
Schedule of
Employee Benefit Plans
|
|
|
2.13
|
Title to
Properties and Encumbrances
|
|
|
2.14
|
Litigation
|
|
|
2.15
|
Patents,
Trademarks, Etc.
|
|
|
|
|
|
|
|
Parent
Disclosure Schedules
|
|
|
3.1
|
Subsidiaries
|
|
|
3.21
|
Schedule of
Parent Bank Accounts
|
|
AGREEMENT OF MERGER AND PLAN OF REORGANIZATION
THIS AGREEMENT OF
MERGER AND PLAN OF REORGANIZATION is made and entered into on
NOVEMBER 17, 2008, by and among ACROSS AMERICA FINANCIAL SERVICES,
INC., a Colorado corporation (“ Parent ”),
ACROSS AMERICA ACQUISITION CORP., a Colorado corporation (“
Acquisition Corp. ”), which is a wholly-owned
subsidiary of Parent, and APRO BIO PHARMACEUTICAL CORPORATION, a
Colorado corporation (the “ Company ”).
W
I T N E S S E T H :
WHEREAS, the Board
of Directors of each of Acquisition Corp., Parent and the Company
have each determined that it is fair to and in the best interests
of their respective corporations and shareholders for Acquisition
Corp. to be merged with and into the Company (the “
Merger ”) upon the terms and subject to the conditions
set forth herein;
WHEREAS, the Board
of Directors of Acquisition Corp. and the Board of Directors of the
Company have approved the Merger in accordance with the Colorado
Business Corporation Act (the “ BCA ”), and upon
the terms and subject to the conditions set forth herein and in the
Statement of Merger (the “ Statement of Merger
”) attached as Exhibit A hereto; and the Board of
Directors of Parent has also approved this Agreement and the
Statement of Merger;
WHEREAS, the
requisite Stockholders have approved, by written consent pursuant
to the BCA, this Agreement and the Statement of Merger and the
transactions contemplated hereby and thereby, including without
limitation, the Merger, and Parent, as the sole stockholder of
Acquisition Corp., has approved this Agreement, the Statement of
Merger and the transactions contemplated and described hereby and
thereby, including without limitation, the Merger; and
WHEREAS, immediately
following the Closing (as such term is defined herein), Parent (as
it will exist as of the closing of the Merger) will sell shares of
its common stock, par value $.001 per share, in a private offering
(the “ Private Offering ”) to accredited
investors, pursuant to the terms of Subscription Agreements for the
purpose of financing the ongoing business and operations of the
Surviving Corporation (as defined below) following the Merger.
NOW, THEREFORE, in
consideration of the mutual agreements and covenants hereinafter
set forth, the parties hereto agree as follows:
. Subject
to the terms and conditions of this Agreement and the Statement of
Merger, Acquisition Corp. shall be merged with and into the Company
in accordance with the BCA. At the Effective Time (as
hereinafter defined), the separate legal existence of Acquisition
Corp. shall cease, and the Company shall be the surviving
corporation in the Merger (sometimes hereinafter referred to as the
“ Surviving Corporation ”) and shall continue
its corporate existence under the laws of the State of Colorado
under the name Aztech Bioscience, Inc., or some derivation
thereof.
. The
Merger shall become effective on the date and at the time the
Statement of Merger is filed with the Secretary of State of the
State of Colorado in accordance with the BCA. The time
at which the Merger shall become effective as aforesaid is referred
to hereinafter as the “ Effective Time .”
1.3
Articles of Incorporation, By-laws, Directors and Officers
.
(a) The
Articles of Incorporation of the Company, as in effect immediately
prior to the Effective Time, attached as Exhibit B hereto,
shall be the Articles of Incorporation of the Surviving Corporation
from and after the Effective Time until further amended in
accordance with applicable law.
(b) The
By-laws of the Company, as in effect immediately prior to the
Effective Time, attached as Exhibit C hereto, shall be the
By-laws of the Surviving Corporation from and after the Effective
Time until amended in accordance with applicable law, the Articles
of Incorporation of the Surviving Corporation and such By-laws.
(c) The
directors and officers listed in Exhibit D hereto shall be
the directors and officers of the Surviving Corporation, and each
shall hold his respective office or offices from and after the
Effective Time (except, in the case of directors, as described in
Section 6.4) until his successor shall have been elected and
shall have qualified in accordance with applicable law, or as
otherwise provided in the Articles of Incorporation or By-laws of
the Surviving Corporation.
1.4
Assets and Liabilities
. At the
Effective Time, the Surviving Corporation shall possess all the
rights, privileges, powers and franchises of a public as well as of
a private nature, and be subject to all the restrictions,
disabilities and duties of each of Acquisition Corp. and the
Company (collectively, the “ Constituent Corporations
”); and all the rights, privileges, powers and franchises of
each of the Constituent Corporations, and all property, real,
personal and mixed, and all debts due to any of the constituent
corporations on whatever account, as well for stock subscriptions
as all other things in action or belonging to each of the
Constituent Corporations, shall be vested in the Surviving
Corporation; and all property, rights, privileges, powers and
franchises, and all and every other interest shall be thereafter as
effectively the property of the Surviving Corporation as they were
of the several and respective constituent corporations, and the
title to any real estate vested by deed or otherwise in either of
the such Constituent Corporations shall not revert or be in any way
impaired by the Merger; but all rights of creditors and all liens
upon any property of any of the Constituent Corporations shall be
preserved unimpaired, and all debts, liabilities and duties of the
Constituent Corporations shall thenceforth attach to the Surviving
Corporation, and may be enforced against it to the same extent as
if said debts, liabilities and duties had been incurred or
contracted by it.
1.5
Manner and Basis of Converting Shares .
(a) At
the Effective Time:
(i) each
share of common stock, par value $.001 per share, of Acquisition
Corp. that shall be outstanding immediately prior to the Effective
Time shall, by virtue of the Merger and without any action on the
part of the holder thereof, be converted into the right to
receive ten (10) shares of common stock, par
value $.001 per share, of the Surviving Corporation, so that at the
Effective Time, Parent shall be the holder of all of the issued and
outstanding shares of the Surviving Corporation;
(ii) the
shares of common stock, par value $.001 per share, of the Company
(the “ Company Common Stock ”), which shares at
the Closing will constitute all of the issued and outstanding
shares of capital stock of the Company, beneficially owned by the
Stockholders listed in Schedule 2.4 (other than shares of
Company Common Stock as to which appraisal rights are perfected
pursuant to the applicable provisions of the BCA and not withdrawn
or otherwise forfeited), shall, by virtue of the Merger and without
any action on the part of the holders thereof, be converted into
the right to receive the number of shares of Parent Common Stock
specified in Schedule 1.5 for each of the Stockholders,
which shall be equal to one share of Parent Common Stock for each
share of Company Common Stock (based on 20,146,962 shares of
Company Common Stock pre-Merger and 2,773,200 shares of Parent
Common Stock on a fully diluted basis allocated to the Stockholders
post-Merger); and
(iii) each
share of Company Common Stock held in the treasury of the Company
immediately prior to the Effective Time shall be cancelled in the
Merger and cease to exist.
(b) After
the Effective Time, there shall be no further registration of
transfers on the stock transfer books of the Surviving Corporation
of the shares of Company Common Stock that were outstanding
immediately prior to the Effective Time.
1.6
Surrender and Exchange of Certificates
. Promptly after the Effective Time and upon (i)
surrender of a certificate or certificates representing shares of
Company Common Stock that were outstanding immediately prior to the
Effective Time or an affidavit and indemnification in form
reasonably acceptable to counsel for the Parent stating that such
Stockholder has lost its certificate or certificates or that such
have been destroyed and (ii) delivery of a Subscription and Lock Up
agreement (as described in Section 4 hereof), Parent shall issue to
each record holder of the Company Common Stock
surrendering such certificate or certificates and Subscription and
Lock Up agreement, a certificate or certificates registered in the
name of such Stockholder representing the number of shares of
Parent Common Stock that such Stockholder shall be entitled to
receive as set forth in Section 1.5(a)(ii) hereof. Until
the certificate, certificates or affidavit is or are surrendered
together with the Subscription and Lock Up agreement as
contemplated by this Section 1.6 and Section 4 hereof, each
certificate or affidavit that immediately prior to the Effective
Time represented any outstanding shares of Company Common Stock
shall be deemed at and after the Effective Time to represent only
the right to receive upon surrender as aforesaid the Parent Common
Stock specified in Schedule 1.5 hereof for the holder thereof or to
perfect any rights of appraisal which such holder may have pursuant
to the applicable provisions of the BCA.
(a) (i) At
the Effective Time, all outstanding warrants issued by the Company
to purchase shares of Company Common Stock (the “ Company
Warrants ”) that have not been surrendered by the holder
thereof in exchange for Company Common Stock, will, at the
Effective Time, be deemed be a warrant (the “ Parent
Warrants ”) to acquire the same number of shares of
Parent Common Stock as the holder of such Company Warrants would
have been entitled to receive pursuant to the Merger had such
holder exercised such Company Warrants in full immediately prior to
the Effective Time at a price per share of Parent Common Stock
equal to the exercise price for the shares of Company Common Stock
otherwise purchasable pursuant to such Company Warrant.
Schedules 2.10 and 1.7(a)(i) attached hereto set forth the
name of each holder of Company Warrants, the aggregate number of
shares of Company Common Stock that each such person may purchase
pursuant to the exercise of his or her Company Warrants and the
aggregate number of shares of Parent Common Stock that each such
person may purchase upon exercise of Parent Warrants acquired
pursuant to this Section 1.7(a)(i). By its signature
hereunder, Parent expressly assumes the obligation to issue Parent
Common Stock to the holders of Parent Warrants upon exercise
thereof, in accordance with the provisions of this Section
1.7(a)(i).
(ii) Without
limiting the generality of the foregoing, the Company and the
Parent shall take all corporate actions as may be necessary and
desirable in order to effectuate the transactions contemplated by
this Section 1.7(a).
(b) Parent
shall take all action necessary and appropriate, on or prior to the
Effective Time, to authorize and reserve a number of shares of
Parent Common Stock sufficient for issuance upon the exercise of
Parent Warrants following the Effective Time as contemplated by
this Section 1.7.
(c) Other
than the Company Warrants, all options, warrants and rights to
purchase Company Common Stock outstanding as of the Effective Date
will be exercised or terminated prior to or effective upon the
Effective Time, and neither Parent nor Acquisition Corp. shall
assume or have any obligation with respect to such options,
warrants or rights.
. Parent
agrees that it will cause the Parent Common Stock into which the
Company Common Stock is converted at the Effective Time pursuant to
Section 1.5(a)(ii) to be available for such
purpose. Parent further covenants that immediately prior
to the Effective Time there will be no more than 1,961,200 shares
of Parent Common Stock issued and outstanding, and that, with the
exception of 812,000 additional shares of Common Stock
issuable pursuant to various warrant, option and other contractual
arrangements, no other common or preferred stock or equity
securities or any options, warrants, rights or other agreements or
instruments convertible, exchangeable or exercisable into common or
preferred stock or other equity securities shall be issued or
outstanding.
2.
Representations and Warranties of the Company
. The Company hereby
represents and warrants to Parent and Acquisition Corp. as
follows:
2.1
Organization, Standing, Subsidiaries, Etc .
(a) The
Company is a corporation duly organized and existing in good
standing under the laws of the State of Colorado, and has all
requisite power and authority (corporate and other) to carry on its
business, to own or lease its properties and assets, to enter into
this Agreement and the Statement of Merger and to carry out the
terms hereof and thereof. Copies of the Articles of
Incorporation and By-laws of the Company that have been delivered
to Parent and Acquisition Corp. prior to the execution of this
Agreement are true and complete and have not since been amended or
repealed.
(b) The
Company has no subsidiaries or direct or indirect interest (by way
of stock ownership or otherwise) in any firm, corporation, limited
liability company, partnership, association or
business. The Company owns all of the issued and
outstanding capital stock or membership interests of the
Subsidiaries free and clear of all Liens, and the Subsidiaries have
no outstanding options, warrants or rights to purchase capital
stock or other equity securities of such Subsidiaries, other than
the capital stock or membership interests owned by the
Company. Unless the context otherwise requires, all
references in this Section 2 to the “Company” shall be
treated as being a reference to the Company and the Subsidiaries
taken together as one enterprise.
. The
Company is duly qualified to conduct business as a foreign
corporation and is in good standing the State of Colorado and in
each other jurisdiction wherein the nature of its activities or its
properties owned or leased makes such qualification necessary,
except where the failure to be so qualified would not have a
material adverse effect on the condition (financial or otherwise),
properties, assets, liabilities, business operations, results of
operations or prospects of the Company taken as a whole (the
“ Condition of the Company ”).
2.3
Capitalization of the Company
. The
authorized capital stock of the Company consists of 210,000,000
shares of Company Capital Stock, $0.001 par value, and the Company
has no authority to issue any other capital stock. There
are 18,189,462 shares of Company Common Stock issued and
outstanding, and such shares are duly authorized, validly issued,
fully paid and nonassessable. Except as disclosed in
Schedules 2.10 and 1.7(a)(i) , the Company has no
outstanding warrants, stock options, rights or commitments to issue
Company Common Stock or other Equity Securities of the Company, and
there are no outstanding securities convertible or exercisable into
or exchangeable for Company Common Stock or other Equity Securities
of the Company.
.
Schedule 2.4 hereto contains a true and complete list of the
names and addresses of the record owner of all of the outstanding
shares of Company Common Stock and other Equity Securities of the
Company, together with the number and percentage (on a
fully-diluted basis) of securities held. To the
knowledge of the Company, except as described in Schedule
2.4 , there is no voting trust, agreement or arrangement among
any of the beneficial holders of Company Common Stock affecting the
exercise of the voting rights of Company Common Stock.
2.5
Corporate Acts and Proceedings
. The
execution, delivery and performance of this Agreement and the
Statement of Merger (together, the “ Merger Documents
”) have been duly authorized by the Board of Directors of the
Company and have been approved by the requisite vote of the
Stockholders, and all of the corporate acts and other proceedings
required for the due and valid authorization, execution, delivery
and performance of the Merger Documents and the consummation of the
Merger have been validly and appropriately taken, except for the
filing of the Statement of Merger referred to in Section 1.2.
2.6
Compliance with Laws and Instruments
. To the
knowledge of the Company, the business, products and operations of
the Company have been and are being conducted in compliance in all
material respects with all applicable laws, rules and regulations,
except for such violations thereof for which the penalties, in the
aggregate, would not have a material adverse effect on the
Condition of the Company. The execution, delivery and
performance by the Company of the Merger Documents and the
consummation by the Company of the transactions contemplated by
this Agreement: (a) will not require any authorization, consent or
approval of, or filing or registration with, any court or
governmental agency or instrumentality, except such as shall have
been obtained prior to the Closing, (b) will not cause the Company
to violate or contravene in any material respect (i) any provision
of law, (ii) any rule or regulation of any agency or government,
(iii) any order, judgment or decree of any court, or (iv) any
provision of the Articles of Incorporation or By-laws of the
Company, (c) will not violate or be in conflict with, result in a
breach of or constitute (with or without notice or lapse of time,
or both) a default under, any indenture, loan or credit agreement,
deed of trust, mortgage, security agreement or other contract,
agreement or instrument to which the Company is a party or by which
the Company or any of its properties is bound or affected, except
as would not have a material adverse effect on the Condition of the
Company, and (d) will not result in the creation or imposition of
any material Lien upon any property or asset of the Company.
. The
Merger Documents constitute the legal, valid and binding
obligations of the Company and are enforceable against the Company
in accordance with their respective terms, except as such
enforcement is limited by bankruptcy, insolvency and other similar
laws affecting the enforcement of creditors’ rights generally
and by general principles of equity.
2.8
Broker’s and Finder’s Fees
. No
Person has, or as a result of the transactions contemplated herein
will have, any right or valid claim against the Company, Parent,
Acquisition Corp. or any Stockholder for any commission, fee or
other compensation as a finder or broker, or in any similar
capacity, except as an advisory fee payable to Bathgate Capital
Parnters, LLC (“BCP”) of 1,750,000 warrants to purchase
common stock of the Parent at $0.001 per share. In
addition, BCP is entitled to receive a six (6%) percent cash
commission and six (6%) warrant coverage pursuant to a private
placement agent agreement with the Parent for the Private
Offering.
. Attached hereto as Schedule 2.9 are the
Company’s audited Consolidated Balance Sheet, Consolidated
Statement of Operations, Consolidated Statement of Changes in
Shareholders’ Equity and Consolidated Statement of Cash Flows
as of and for the year ended March 31, 2007, and the
Company’s unaudited Consolidated Balance Sheet (the “
Balance Sheet ”) as of September 30, 2008 (the “
Balance Sheet Date ”) and related Statement of
Operations, Consolidated Statement of Changes in
Shareholders’ Equity and Consolidated Statement of Cash Flows
as of and for the nine months ended September 30,
2008. Such financial statements (i) are in accordance
with the books and records of the Company, (ii) present fairly in
all material respects the financial condition of the Company at the
dates therein specified and the results of its operations and
changes in financial position for the periods therein specified and
(iii) have been prepared in accordance with generally accepted
accounting principles (“ GAAP ”) applied on a
basis consistent with prior accounting periods.
2.10
Absence of Undisclosed Liabilities
. The
Company has no material obligation or liability (whether accrued,
absolute, contingent, liquidated or otherwise, whether due or to
become due), arising out of any transaction entered into at or
prior to the Closing, except (a) as disclosed in Schedule
2.10 and/or Schedule 2.11 hereto, (b) to the extent set
forth on or reserved against in the Balance Sheet, (c) current
liabilities incurred and obligations under agreements entered into
in the usual and ordinary course of business since the Balance
Sheet Date, none of which (individually or in the aggregate) has
had or will have a material adverse effect on the Condition of the
Company and (d) by the specific terms of any written agreement,
document or arrangement identified in the Schedules.
. Since
the Balance Sheet Date, except as disclosed in Schedule 2.11
hereto, the Company has not (a) incurred any debts, obligations or
liabilities, absolute, accrued, contingent or otherwise, whether
due or to become due, except for fees, expenses and liabilities
incurred in connection with the Merger and related transactions and
current liabilities incurred in the usual and ordinary course of
business, (b) discharged or satisfied any Liens other than those
securing, or paid any obligation or liability other than, current
liabilities shown on the Balance Sheet and current liabilities
incurred since the Balance Sheet Date, in each case in the usual
and ordinary course of business, (c) mortgaged, pledged or
subjected to Lien any of its assets, tangible or intangible, other
than in the usual and ordinary course of business, (d) sold,
transferred or leased any of its assets, except in the usual and
ordinary course of business, (e) cancelled or compromised any debt
or claim, or waived or released any right, of material value, (f)
suffered any physical damage, destruction or loss (whether or not
covered by insurance) materially and adversely affecting the
Condition of the Company, or (g) entered into any transaction other
than in the usual and ordinary course of business.
2.12
Employee Benefit Plans; ERISA
.
Schedule 2.12 lists all: (i) "employee
benefit plans" as defined in Section 3(3) of the Employee
Retirement Income Security Act of 1974, as amended (“
ERISA ”), maintained or contributed to by the Company
and covering employees of the Company, including (i) any such plans
that are "employee welfare benefit plans" as defined in Section
3(1) of ERISA and (ii) any such plans that are "employee pension
benefit plans" as defined in Section 3(2) of ERISA (collectively,
the “ Company Benefit Plans ”); and (ii) life
and health insurance, hospitalization, savings, bonus, deferred
compensation, incentive compensation, holiday, vacation, severance
pay, sick pay, sick leave, disability, tuition refund, service
award, company car, scholarship, relocation, patent award, fringe
benefit and other employee benefit plans, contracts (other than
individual employment, consultancy or severance contracts),
policies or practices of the Company providing employee or
executive compensation or benefits to its employees, other than the
Company Benefit Plans (collectively, the “ Benefit
Arrangements ”). Each Company Benefit Plan and
Benefit Arrangement has been maintained and administered in all
material respects in accordance with applicable law.
2.13
Title to Property and Encumbrances
. Except
as disclosed in Schedule 2.13 hereto, the Company has good,
valid and indefeasible marketable title to all properties and
assets used in the conduct of its business (except for property
held under valid and subsisting leases which are in full force and
effect and which are not in default) free of all Liens and other
encumbrances, except Permitted Liens and such ordinary and
customary imperfections of title, restrictions and encumbrances as
do not, individually or in the aggregate, materially detract from
the value of the property or assets or materially impair the use
made thereof by the Company in its business. Without limiting the
generality of the foregoing, the Company has good and indefeasible
title to all of its properties and assets reflected in the Balance
Sheet, except for property disposed of in the usual and ordinary
course of business since the Balance Sheet Date and for property
held under valid and subsisting leases which are in full force and
effect and which are not in default.
. Except
as set forth on Schedule 2.14 , there is no legal action,
suit, arbitration or other legal, administrative or other
governmental proceeding pending or, to the best knowledge of the
Company, threatened against or affecting the Company or its
properties, assets or business, and after reasonable investigation,
the Company is not aware of any incident, transaction, occurrence
or circumstance that might reasonably be expected to result in or
form the basis for any such action, suit, arbitration or other
proceeding. The Company is not in default with respect
to any order, writ, judgment, injunction, decree, determination or
award of any court or any governmental agency or instrumentality or
arbitration authority.
2.15
Patents, Trademarks, Etc.
Schedule 2.15 sets forth a list of all United States and
foreign patents, trademarks, trade names, copyrights, and
applications therefor used by the Company exclusively in and
material to the conduct of its business (the “ Patent and
Trademark Rights ”). Such Patent and Trademark
Rights are used by the Company pursuant to licenses as described on
Schedule 2.15 , and are not owned directly by the
Company. Except as disclosed in Schedule 2.15 ,
(a) the Company owns or possesses adequate licenses or other valid
rights to use all Patent and Trademark Rights; and (b) to the
Company’s knowledge, the conduct of its business as now being
conducted does not conflict with any valid patents, trademarks,
trade names or copyrights of others in any way which has a material
adverse effect on the business or financial condition of the
Company or its business.
There is
no fact relating to the Company that the Company has not disclosed
to Parent that materially and adversely affects or, insofar as the
Company can now foresee, will materially and adversely affect, the
condition (financial or otherwise), properties, assets,
liabilities, business operations or results of operations of the
Company. No representation or warranty by the Company
herein and no information disclosed in the schedules or exhibits
hereto by the Company contains any untrue statement of a material
fact or omits to state a material fact necessary to make the
statements contained herein or therein not misleading.
3.
Representations and Warranties of Parent and Acquisition
Corp .
Parent
and Acquisition Corp. jointly and severally represent and warrant
to the Company, as follows:
3.1
Organization and Standing
. Parent
is a corporation duly organized and existing in good standing under
the laws of the State of Colorado. Acquisition Corp. is
a corporation duly organized and existing in good standing under
the laws of the State of Colorado. Parent and
Acquisition Corp. have heretofore delivered to the Company complete
and correct copies of their respective Articles or Certificates of
Incorporation and By-laws as now in effect. Parent and
Acquisition Corp. have full corporate power and authority to carry
on their respective businesses as they are now being conducted and
as now proposed to be conducted and to own or lease their
respective properties and assets. Except as disclosed in
Schedule 3.1 hereto, neither Parent nor Acquisition Corp.
has any subsidiaries (except Parent as the sole stockholder of
Acquisition Corp.) or direct or indirect interest (by way of stock
ownership or otherwise) in any firm, corporation, limited liability
company, partnership, association or business. Parent
owns all of the issued and outstanding capital stock of Acquisition
Corp. free and clear of all Liens, and Acquisition Corp. has no
outstanding options, warrants or rights to purchase capital stock
or other equity securities of Acquisition Corp., other than the
capital stock owned by Parent. Unless the context
otherwise requires, all references in this Section 3 to the
“Parent” shall be treated as being a reference to the
Parent and Acquisition Corp. taken together as one enterprise.
. Each of
Parent and/or Acquisition Corp. (as the case may be) has full
corporate power and authority to enter into the Merger Documents
and the other agreements to be made pursuant to the Merger
Documents, and to carry out the transactions contemplated hereby
and thereby. All corporate acts and proceedings required for the
authorization, execution, delivery and performance of the Merger
Documents and such other agreements and documents by Parent and/or
Acquisition Corp. (as the case may be) have been duly and validly
taken or will have been so taken prior to the
Closing. Each of the Merger Documents constitutes a
legal, valid and binding obligation of Parent and/or Acquisition
Corp. (as the case may be), each enforceable against them in
accordance with their respective terms, except as such enforcement
may be limited by bankruptcy, insolvency, reorganization or other
similar laws affecting creditors’ rights generally and by
general principles of equity.
3.3
Broker’s and Finder’s Fees
. Except
for the firms engaged by the Company described in Section 2.8, no
person, firm, corporation or other entity is entitled by reason of
any act or omission of Parent or Acquisition Corp. to any
broker’s or finder’s fees, commission or other similar
compensation with respect to the execution and delivery of this
Agreement or the Statement of Merger, or with respect to the
consummation of the transactions contemplated hereby or
thereby. Parent and Acquisition Corp. jointly and
severally indemnify and hold Company harmless from and against any
and all loss, claim or liability arising out of any such claim from
any other Person who claims he, she or it introduced Parent or
Acquisition Corp. to, or assisted them with, the transactions
contemplated by or described herein.
3.4
Capitalization of Parent
. The
authorized capital stock of Parent consists of (a) 50,000,000
shares of common stock, par value $.001 per share (the “
Parent Common Stock ”), of which not more than
1,961,200 shares will be, prior to the Effective Time, issued and
outstanding, and (b) 1,000,000 shares of preferred stock, par value
$.01 per share, of which no shares are issued or
outstanding. Other than 812,000
additional shares of Common Stock issuable pursuant to
various warrant, option and other contractual arrangements,, Parent
has no outstanding options, rights or commitments to issue shares
of Parent Common Stock or any other Equity Security of Parent or
Acquisition Corp., and there are no outstanding securities
convertible or exercisable into or exchangeable for shares of
Parent Common Stock or any other Equity Security of Parent or
Acquisition Corp. There is no voting trust, agreement or
arrangement among any of the beneficial holders of Parent Common
Stock affecting the nomination or election of directors or the
exercise of the voting rights of Parent Common
Stock. All outstanding shares of the capital stock of
Parent are validly issued and outstanding, fully paid and
nonassessable, and none of such shares have been issued in
violation of the preemptive rights of any person.
Acquisition
Corp. is a wholly-owned subsidiary of Parent that was formed
specifically for the purpose of the Merger and that has not
conducted any business or acquired any property, and will not
conduct any business or acquire any property prior to the Closing
Date, except in preparation for and otherwise in connection with
the transactions contemplated by this Agreement, the Statement of
Merger and the other agreements to be made pursuant to or in
connection with this Agreement and the Statement of Merger.
. The
17,919,733 shares of Parent Common Stock to be issued at the
Closing pursuant to Section 1.5(a)(ii) hereof, when issued and
delivered in accordance with the terms hereof and of the Statement
of Merger, shall be duly and validly issued, fully paid and
nonassessable. Based in part on the representations and
warranties of the Stockholders as contemplated by Section 4 hereof
and assuming the accuracy thereof, the issuance of the Parent
Common Stock upon the Merger pursuant to Section 1.5(a)(ii) will be
exempt from the registration and prospectus delivery requirements
of the Securities Act and from the qualification or registration
requirements of any applicable state blue sky or securities
laws.
3.7
SEC Reporting and Compliance
. (a) Parent filed a registration statement
on Form SB-2 under the Exchange Act which became effective on March
19, 2007, Parent has filed with the Commission all reports required
to be filed by companies registered pursuant to Section 12(g) of
the Exchange Act.
(b) Parent
has delivered to the Company true and complete copies of all annual
reports on Form 10-KSB, quarterly reports on Form 10-QSB and Form
10-Q, current reports on Form 8-K and other statements reports and
filings (collectively, the “ Parent SEC Documents
”) filed by the Parent with the Commission.
(c) Parent
has not filed, and nothing has occurred with respect to which
Parent would be required to file, any report on Form 8-K since
November 7, 2008. Prior to and until the Closing, Parent
will provide to the Company copies of any and all amendments or
supplements to the Parent SEC Documents filed with the Commission
since November 7, 2008 and any and all subsequent statements,
reports and filings filed by the Parent with the Commission or
delivered to the stockholders of Parent.
(d) The
shares of Parent Common Stock are quoted on the Over-the-Counter
(OTC) Bulletin Board under the symbol “AAFS.OB,” and
Parent is in compliance in all material respects with all rules and
regulations of the OTC Bulletin Board applicable to it and the
Parent Stock.
|